title: Side effects of targeted therapies: rash.
abstract: OBJECTIVE
  To present a thorough literature review on the assessment, grading, and treatment of rash associated with targeted therapies for cancer treatment. To identify ways that nursing can impact a patient's treatment experience by understanding and properly managing treatment for the rash.
  
  
  METHODS
  Peer-reviewed journal articles, textbooks.
  
  
  CONCLUSIONS
  Identification and management of rash induced by targeted therapies may improve quality of life and allow patients to continue drug therapy for their cancer to offer best outcomes.
  
  
  CONCLUSIONS
  Nurses are in a unique position to assess, grade, and manage rash in patients receiving targeted therapies. Nurses will often be the first point of contact for the patient experiencing a rash, and the proper triage and advice on management can help the patient tolerate these drugs and enable them to remain on treatment.
authors.forename: Beth
authors.initials: B
authors.lastname: Eaby-Sandy
authors.forename: Kathy
authors.initials: K
authors.lastname: Lynch
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors
keywords: EGFR rash; Papulopustular rash; dermatologic toxicities